In 2015, Stelloo et al. (25) proposed a simplified endometrial cancer classification system using surrogate molecular markers, and identified four prognostic groups including POLE mutant, MSI-H, TP53 mutant, and no specific molecular profile (NSMP) group. This evidence concerns the gene TP53 and endometrial cancer.